Selegiline hydrochloride is the generic ingredient in three branded drugs marketed by Somerset, Apotex, Dava Pharms Inc, Lannett Holdings Inc, Valeant Pharm Intl, Apotex Inc, Ivax Sub Teva Pharms, Mylan, Siegfried, Stason, Teva, and Vintage Pharms Llc, and is included in fifteen NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.
There are fifteen drug master file entries for selegiline hydrochloride. Two suppliers are listed for this compound.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Type||RLD||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|TABLET;ORAL||019334||Jun 5, 1989||DISCN||No||<disabled>||<disabled>|
Valeant Pharm Intl
|TABLET, ORALLY DISINTEGRATING;ORAL||021479||Jun 14, 2006||RX||Yes||5,648,093||<disabled>||Y||<disabled>|
Valeant Pharm Intl
|TABLET, ORALLY DISINTEGRATING;ORAL||021479||Jun 14, 2006||RX||Yes||6,423,342||<disabled>||Y||<disabled>|
|CAPSULE;ORAL||020647||May 15, 1996||RX||Yes||<disabled>||<disabled>|
|TABLET;ORAL||074871||Jun 6, 1997||RX||Yes||<disabled>||<disabled>|
|This preview shows a limited data set|
Subscribe for full access, or try a free trial
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.